Clinical trial Recruiting at 1 site Observational

Clinical features and molecular drivers of obstructive sleep apnea

Official title: Clinical Characteristics and Molecular Mechanism of Patients With Obstructive Sleep Apnea

Run by Capital Medical University · NCT07277608 · Data updated 2026-11-12

This project will collect clinical and molecular data from people with obstructive sleep apnea to see how disease severity affects prognosis, immunity, and metabolism.

Quick facts

Study typeObservational
SexAll
Enrollment500 (estimated)
SponsorCapital Medical University
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedAugust 7, 2023
Main results expectedAugust 7, 2033
Study endsAugust 7, 2033
Registry record updatedDecember 11, 2025
Trial IDNCT07277608 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with suspected or confirmed obstructive sleep apnea seen at Beijing Chaoyang Hospital's sleep center who can consent and commit to at least one year of follow-up and sample collection.

Probably not a fit

Patients who are pregnant or lactating, have severe organ failure, require mechanical ventilation, are already unable to comply with follow-up, or refuse biological sampling are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project will enroll patients with suspected obstructive sleep apnea at the sleep center of Beijing Chaoyang Hospital and build a multi-omics database from clinical data and biological samples. Investigators will compare immune, metabolic, and outcome patterns across different OSA severity levels and follow participants for at least one year to document prognosis, complications, and comorbidities. The study aims to track immune and metabolic dynamics after treatment and to identify biomarkers and potential therapeutic targets associated with OSA. Participants must consent to sample collection and follow-up, while those with major organ failure, pregnancy/lactation, or inability to comply with follow-up are excluded.

Why it matters

Potential benefit: If successful, the work could identify biomarkers and targets that improve prognosis prediction and enable more personalized treatment for people with OSA.

How similar studies have gone: Previous studies using molecular and metabolic profiling have shown associations between OSA and immune/metabolic changes, but comprehensive multi-omics biomarker panels for prognosis remain largely unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with suspected obstructive sleep apnea (OSA) admitted to the sleep center of the respiratory Department of Beijing Chaoyang Hospital, Capital Medical University.
* Volunteer to participate in the study and sign an informed consent, and can complete at least 1 year of follow-up.

Exclusion Criteria:

* Patients with obstructive sleep apnea who have been treated with impermanent positive pressure ventilation;
* Pregnant or lactating women;
* Patients with severe respiratory failure requiring mechanical ventilation;
* Patients with severe heart, lung, liver, kidney, and central nervous system damage;
* Refuse to participate in follow-up visits and/or take biological samples.

Where it's running

  • Beijing Chaoyang hospital affiliated to Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.